Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Plos One
|
September 17, 2013
Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress
Carlos Farkas, Carla P Martins, David Escobar, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
March 6, 2024
Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases
Tommaso Pollini, Thuy Tran, Paul Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity
Vered Stearns, Ann Gallagher, Celina G Kleer, et al.
Biomedical Optics Express
|
May 9, 2012
Tissue phantoms in multicenter clinical trials for diffuse optical technologies
Albert E Cerussi, Robert Warren, Brian Hill, et al.
Breast Cancer Research and Treatment
|
October 27, 2010
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
Claudine Isaacs, Pia Herbolsheimer, Minetta C Liu, et al.
Nature Cell Biology
|
May 26, 2015
RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth
Philippe Depeille, Linda M Henricks, Robert A H van de Ven, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 14, 2016
Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety
Margaret E Gatti-Mays, David Venzon, Claudia E Galbo, et al.
Plos Computational Biology
|
November 24, 2020
Transforming the study of organisms: Phenomic data models and knowledge bases
Anne E Thessen, Ramona L Walls, Lars Vogt, et al.
Breast Cancer Research and Treatment
|
October 24, 2022
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
Paula R Pohlmann, Deena Graham, Tianmin Wu, et al.
The American Journal of Cardiology
|
October 1, 2013
Relation of electrocardiographic changes in pulmonary embolism to right ventricular enlargement
Paul D Stein, Fadi Matta, Michel J Sabra, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Plos One
|
September 17, 2013
Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress
Carlos Farkas, Carla P Martins, David Escobar, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
March 6, 2024
Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases
Tommaso Pollini, Thuy Tran, Paul Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity
Vered Stearns, Ann Gallagher, Celina G Kleer, et al.
Biomedical Optics Express
|
May 9, 2012
Tissue phantoms in multicenter clinical trials for diffuse optical technologies
Albert E Cerussi, Robert Warren, Brian Hill, et al.
Breast Cancer Research and Treatment
|
October 27, 2010
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
Claudine Isaacs, Pia Herbolsheimer, Minetta C Liu, et al.
Nature Cell Biology
|
May 26, 2015
RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth
Philippe Depeille, Linda M Henricks, Robert A H van de Ven, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 14, 2016
Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety
Margaret E Gatti-Mays, David Venzon, Claudia E Galbo, et al.
Plos Computational Biology
|
November 24, 2020
Transforming the study of organisms: Phenomic data models and knowledge bases
Anne E Thessen, Ramona L Walls, Lars Vogt, et al.
Breast Cancer Research and Treatment
|
October 24, 2022
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
Paula R Pohlmann, Deena Graham, Tianmin Wu, et al.
The American Journal of Cardiology
|
October 1, 2013
Relation of electrocardiographic changes in pulmonary embolism to right ventricular enlargement
Paul D Stein, Fadi Matta, Michel J Sabra, et al.
Page
of 10